|
|
|
Volumn 50, Issue 42, 2001, Pages 909-919
|
|
Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
CIPROFLOXACIN;
DOXYCYCLINE;
ADULT;
ANTHRAX;
ANTIBIOTIC PROPHYLAXIS;
ARTICLE;
BACILLUS ANTHRACIS;
BACTERIAL SKIN DISEASE;
BACTERIAL SPORE;
BIOLOGICAL WARFARE;
CHILD;
DRUG EFFECT;
FEMALE;
GENETICS;
GOVERNMENT;
HUMAN;
ISOLATION AND PURIFICATION;
MALE;
MICROBIOLOGICAL EXAMINATION;
MIDDLE AGED;
OCCUPATIONAL EXPOSURE;
POSTAL MAIL;
PUBLIC HEALTH SERVICE;
RESPIRATORY TRACT INFECTION;
UNITED STATES;
ADULT;
ANTHRAX;
ANTI-BACTERIAL AGENTS;
ANTIBIOTIC PROPHYLAXIS;
BACILLUS ANTHRACIS;
BIOTERRORISM;
CHILD;
CIPROFLOXACIN;
DISTRICT OF COLUMBIA;
DOXYCYCLINE;
FEMALE;
FLORIDA;
GOVERNMENT AGENCIES;
HUMANS;
MALE;
MARYLAND;
MICROBIAL SENSITIVITY TESTS;
MIDDLE AGED;
NEW JERSEY;
NEW YORK;
OCCUPATIONAL EXPOSURE;
POSTAL SERVICE;
PUBLIC HEALTH PRACTICE;
RESPIRATORY TRACT INFECTIONS;
SKIN DISEASES, BACTERIAL;
SPORES, BACTERIAL;
UNITED STATES;
VIRGINIA;
|
|
EID: 0035955707
PISSN: 01492195
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (257)
|
|
References (0)
|